Pinned Tweet
Well, it seems that I’m a lily (a bad one) 😊 My sincere thanks 🙏 to the editors.
Replying to @BadLilies
Featuring @KathrynSimmonds @jessmkrjy Rebecca Watts @amonochromdream @LAHMCCABE @GBClarkson @erinowhat @matriches @chamiltonemery @Nikita_azad @alexjenkinspoet @GarethPrior badlilies.uk/issue-nine
Much applause and appreciation from this UTUC patient! 👏🏻
Our paper IMPACT UTUC is now published in @NatRevUrol: an international multidisciplinary Delphi consensus on #UTUC
doi.org/10.1038/s41585-026-0…
@ricautor @RobertoContieri @LauraBukavinaMD @urodocash @PGrivasMDPhD @montypal @sonpavde @AndreaNecchi @jteoh_hk @carme_mir1
1
83
It is actually really really hard for some patients to report for a myriad of reasons— wanting to appear strong and stoic, not wanting to be seen as a ‘complainer’, the fear that adjusting or curtailing treatment may mean the cancer will return, not wanting to disappoint their loved ones and medical team. The whole culture around cancer heroics feeds into this. Every patient needs to feel and understand that reporting is not a reflection on their character, nor is it giving up.
“Don't ignore side effects. Report them.”
This is the message of #MedSafetyWeek 2026 (November 2–8), a global campaign supported by the @WHO, highlighting the importance of recognizing and reporting suspected adverse drug reactions.
In oncology, this message is particularly important. Cancer treatments can cause a wide range of side effects, and knowing when to seek medical attention can make a critical difference in patient safety.
Marking MedSafetyWeek 2026, OncoDaily takes a closer look at cancer treatment side effects, warning signs that should never be ignored, and the importance of timely reporting.
@UMCGlobalSafety
Read more: oncodaily.com/oncolibrary/ca…
56
As a patient I’m always happy to see a dedicated agenda item — the uro-oncologists discussing UTUC — in my own backyard.
Join us in 1 week in Halifax! For more info regarding program and registration, click here >>>cua.org/event/245863
1
46
Promising news for LG UTUC! And what of the HG patient with disease in their remaining kidney — Down the road, could this treatment potentially be a kidney-sparing option for select HG patients? Perhaps a naive question— but a question and a worry that keeps UTUC patients up at night.
New five-year follow-up data from the Olympus study reinforce the long-term durability of response among adults with low-grade upper tract urothelial cancer (LG-UTUC) who achieved a complete response. Learn more about the final results: investors.urogen.com/news-re…
51
Yes to co-operative UTUC trials. Upper tract Patients know it is difficult, but when has difficult stopped the world's best GU oncologists? Please do not forget about us.
Limited ADC+IO data in perioperative UTUC.
WUTSUP-02: Neoadj DV + tislelizumab achieved 28% pCR vs 19% with gem/cis in phase II trial MSK trial (cross-trial comparison).
Promising, but modest activity. Cooperative group trials are needed to define optimal therapy for UTUC.
#ESMO26 @OncoAlert @BladderCancerUS
64
Thank you to @tompowles1 for asking the question and to The @Uromigos and @shilpaonc for this very important conversation about Upper Tract Urothelial Carcinoma. Yes to a trial and yes to well-considered options for UTUC patients while we wait! It does my heart good to see this complex disease get continued attention post POUT.
creators.spotify.com/pod/pro…
It looks like we’re not sure about the best systemic approach to upper tract urothelial cancer. Data for nivolumab in Upper tract disease is not great (DFS HR- 1.23 (0.67-2.23), while the carboplatin subset of POUT was also underwhelming (OS HR 0.87: 0.50-1.53). ctDNA appeared to work for UTUC in IM010 but was excluded in IM011 due to concerns from the nivo data in this subgroup. EVP has always beaten everything else in UC, and upper tract subsets of 302 looked good - but there in no adjuvant data. What to do? I’m not sure. In ctDNA positives I might be tempted to go with EVP and survey the -ves (and give EVP if they relapse), but it feel a long way off piste! @MattGalsky @OncoAlert @montypal @DrChoueiri @AlisonBirtle
The morning after ‘Canada Walk’s for Bladder Cancer’ a visit to the Halifax Public Gardens. Hope Blooms!
7
101
Halifax we did it! — the walk was really quite emotional and I wish it could have gone on for much longer — the experience of walking and talking with other patients and sharing our stories, witnessing so many gathered to support their loved ones, the cool autumn air and the light on the water of Halifax harbour, the photo bombing golden retriever who brought me his ball (dogs know 😊).
And the local organizers! — a group of young Dalhousie students who show up year after year — whose only connection to bladder cancer is they saw a good cause and committed themselves to it. A special shout out to and big hug for Michael— a third year Dal medical student (local boy from Hubbards — he went to school in Chester) who led the walk with a skilled and gracious hand.
All my dear people who donated — your generousity enabled me to achieve my personal goal literally a thousand fold. Pretty humbling, pretty grateful. Your donations really matter. Bladder Cancer is chronically underfunded and every dollar helps us raise awareness, support patients, and contribute to life extending research.
My cup runs over.
4
152
Lisa McCabe retweeted
Happy to have a sonnet in the fine new issue of @PoemsforPOI. Thanks to editors @AlexRettie and @SarahInkspires!
As I gear up (yes, I need new sneakers!) for the Bladder Cancer Canada walk on September 19th (the Halifax NS version), I’m also gearing up for my next round of badder cancer treatments at the end of the month. For me this walk is truly personal — the funds I raise with your assistance contribute to important research that will extend and improve the lives of every bladder cancer patient — myself included. This important study — pubmed.ncbi.nlm.nih.gov/4216… — out of the University of British Columbia (and partially funded by Bladder Cancer Canada) is just one such example. Please help patients such as me and the Canadian doctors and scientists that work on our behalf get across the finish line — the one on September 19th, the one that brings us closer to finding definitive treatments.
To support my walk —
fundraise.bladdercancercanad…
Lisa McCabe retweeted
Funeral director Thomas Lynch bringing the undertaker's eye for stillness to this late-summer sonnet
In my mind I still see her walking — my childhood friend Ingrid— missing now 54 years on August 16th. My poem for her.
yrp.ca/cold-cases/ingrid-bau…































